Home › Funds › TimesSquare Capital Management, LLC › IONS

TimesSquare Capital Management, LLC position in IONS

IONIS PHARMACEUTICALS INC · Health Care

TimesSquare Capital Management, LLC reported holding 614,070 shares of IONS (IONIS PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$48.7M, representing 0.72% of its reported portfolio and ranking #49 among its reported holdings. TimesSquare Capital Management, LLC has disclosed IONS holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)614.07K sh
Reported value held$48.69M
Portfolio Weight0.72%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TimesSquare Capital Management, LLC's IONS position evolved

TimesSquare Capital Management, LLC first disclosed a stake in IONS in Q1 2026 at 275,674 shares (US$20.7M). The position peaked in Q2 2026 at 614,070 shares, worth US$48.7M. Across 2 filings, TimesSquare Capital Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 614,070 shares valued at US$48.7M — an increase of 338,396 shares quarter over quarter.. Notable position changes include a 123% increase in Q2 2026 (shares fell 44% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 275.67K $20.70M New
Q2 2026 614.07K $48.69M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IONS and 13F data

IONS (IONIS PHARMACEUTICALS INC) is a Health Care company. 42 other funds we track also report a position in IONS — the largest reported positions include Two Sigma Investments (US$495.7M), TWO SIGMA ADVISERS, LP (US$241.5M), Tweedy, Browne Co LLC (US$180.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IONS

All IONS fund holders →

FAQ

How long has TimesSquare Capital Management, LLC held IONS?

TimesSquare Capital Management, LLC has disclosed IONS holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is TimesSquare Capital Management, LLC's current position in IONS?

As of Q2 2026, TimesSquare Capital Management, LLC holds 614.07K shares of IONS (IONIS PHARMACEUTICALS INC), valued at $48.69M, representing 0.72% of its reported portfolio and ranking #49.

Has TimesSquare Capital Management, LLC been buying or selling IONS?

In the latest 13F filing (Q2 2026), TimesSquare Capital Management, LLC increased its position in IONS. The position peaked in Q2 2026 at 614.07K shares.

Which other funds hold IONS?

Other major institutional holders of IONS include Two Sigma Investments, TWO SIGMA ADVISERS, LP, Tweedy, Browne Co LLC, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.